Figure 2

Disruption of CRT/LRP phagocytic signalling inhibits primary phagocytosis induced by LPS or Aβ. (A, C+E) Co-cultures of cerebellar neurons and glia were treated with 100ng/ml LPS for 72hours in the presence of 1μg/ml CRT-blocking antibody (A), 250 nM RAP (C) or 1μg/ml LRP-blocking antibody (E). In (A) and (E) normal mouse IgG (mIgG) was added to control for non-specific effects of CRT- and LRP-blocking antibodies. In (C) and (I) ‘control’ refers to addition of PBS alone as RAP was dissolved in PBS prior to addition. Neuronal survival was quantified using Hoechst/PI staining after 72hours. (B, D+F) Production of nitrite as a measure of microglial activation was measured in cell culture supernatants from experiments shown in (A) (B), (C) (D) and (E) (F). (G-J) Cerebellar co-cultures were treated with 250 nM Aβ peptide for 72hours in the presence of CRT-blocking antibody (G+H) or RAP (I+J) prior to quantification of neuronal survival (G+I) and microglial density (H+J). All data represent the mean value of three separate experiments (two replicates per experiment). Error bars represent SEM. Aβ, amyloid-β peptide_1-42; CRT, calreticulin; LPS, lipopolysaccharide; LRP, low-density lipoprotein receptor-related protein; RAP, receptor-associated protein.